Healthequity (HQY) Change in Accured Expenses (2013 - 2026)

Healthequity's Change in Accured Expenses history runs 14 years deep, the most recent figure standing at -$873000.0 for Q2 2026.

• In Q2 2026, Change in Accured Expenses fell 125.51% year-over-year to -$873000.0; the TTM figure through Apr 2026 stood at -$13.1 million (down 155.68% YoY), while the FY2026 annual figure was -$8.8 million, down 149.59% from the prior year.
• Change in Accured Expenses for Q2 2026 stood at -$873000.0, down from $2.5 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $37.5 million in Q4 2024, with the low at -$25.4 million in Q2 2023.
• The 5-year median for Change in Accured Expenses is -$4.3 million (2023), against an average of -$242055.6.
• The sharpest annual moves came in 2022 and 2024: Change in Accured Expenses sank 3503.94% in 2022, then surged 691.55% in 2024.
• Healthequity's Change in Accured Expenses stood at $14.0 million in 2022, then slumped by 145.38% to -$6.3 million in 2023, then soared by 691.55% to $37.5 million in 2024, then slumped by 119.98% to -$7.5 million in 2025, then jumped by 88.34% to -$873000.0 in 2026.
• Business Quant data shows HQY's Change in Accured Expenses at -$873000.0 in Q2 2026, $2.5 million in Q1 2026, and -$7.5 million in Q4 2025.